Andere talen Physiomics Plc

Aandelen

Beurs gesloten - London S.E. Andere beurzen 17:35:23 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
1,5 ^GBX	0,00%		+15,38%	-6,25%

18/03	Transcript : Physiomics Plc, H1 2024 Earnings Call, Mar 18, 2024
18/03	Physiomics viert "substantieel" contract met oude klant	AN

Physiomics celebrates "substantial" contract with old client	18/03
Physiomics Wins DNA-related Modeling Contract with Large Pharmaceutical Company	18/03
Physiomics plc Wins Contract by an Existing Pharma Client	18/03
Physiomics reports higher interim revenue; loss narrows	07/03
Physiomics Plc Reports Earnings Results for the Half Year Ended December 31, 2023	07/03
Physiomics celebrates contract award for cancer therapy insect model	19/02
The University of Sheffield Selects Physiomics plc to Support a Grant funded Project Focused on an Insect (Fruit Fly) Model of Cancer Treatment	19/02
Physiomics wins deal to support client's oncology assets	05/02
Physiomics plc Announces Contract Award	05/02
Physiomics appoints COO Sargent as new CEO; completes restructuring	22/01
Physiomics Names CEO as Nonexecutive Chairman	22/01
Physiomics Names CEO as Chairman	22/01
Physiomics plc Announces Chief Executive Officer Changes	22/01
Physiomics plc Announces Executive Changes	22/01
ValiRx Plc - ValiRx 2023, a year in review	20/12
Physiomics Secures Grant to Advance Personalized Chemotherapy Tool in UK	10/11
Physiomics gets UK government grant for oncology dosing tool project	10/11
Physiomics plc Announces Change of Registered Office	04-10-23
Physiomics Plc Appoints Dr Venkata Putcha, as Head of Biostatistics	03-10-23
Physiomics shares drop as annual loss widens; revenue falls	28-09-23

Geen resultaten voor deze zoekopdracht